You are here: Industry Insights > Novo Nordisk

News List

AMAG Pharmaceuticals Appoints New Members…… firstwordpharma
April 15, 2019
AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) today announced the election of two new members to its Board of ……
Novo plunks down $100M to ready plant for new-generation insulins fiercepharma
April 02, 2019
Novo Nordisk this last week reached an agreement that will hold off generic competition to its newer……
Novo Nordisk settles Victoza patent dispute with Teva in US pharmaceutical-technology
March 20, 2019
Available in pre filled pens, Victoza is indicated to improve glycemic control in type 2 diabetes. Credit: Novo Nordisk A/S.
Study shows reduced hypoglycaemia after switch to Tresiba pharmatimes
March 12, 2019
New data from Novo Nordisk has shown that people with type I or type II diabetes who were switched to Tresiba (insulin degludec) by their doctor from other basal insulins achieved significantly reduced rates of hypoglycaemia, along with reduction in blood
Study shows reduced hypoglycaemia after switch to Tresiba pharmatimes
March 12, 2019
New data from Novo Nordisk has shown that people with type I or type II diabetes who were switched to Tresiba (insulin degludec) by their doctor from other basal insulins achieved significantly reduced rates of hypoglycaemia, along with reduction in blood
Now that Lilly has a cheaper generic Humalog, will Novo Nordisk and Sanofi follow? fiercepharma
March 08, 2019
Caught by an outcry over high insulin prices, Eli Lilly recently unveiled an authorized generic version of its Humalog insulin at half the price of the original brand.
Novo Nordisk Pharma Ltd. partners with Health2Sync in Japan, bringing digital diabetes management to healthcare providers and patients firstwordpharma
March 06, 2019
Health2Sync and Novo Nordisk Pharma Ltd. are partnering in Japan to support digital diabetes management and facilitate communication between diabetics and healthcare providers.
Novo Nordisk, Health2Sync collaborate for digital diabetes management biospectrumasia
March 06, 2019
Health2Sync and Novo Nordisk Pharma Ltd. are partnering in Japan to support digital diabetes management and facilitate communication between diabetics and healthcare providers. Last December, the two companies agreed to support the localization and promot
Ozempic® superior in lowering blood sugar and weight vs placebo, both in combination with SGLT-2 inhibitors worldpharmanews
March 06, 2019
Novo Nordisk announced publication of results from the SUSTAIN 9 Phase 3b trial in The Lancet Diabetes & Endocrinology.
Novo Nordisk nabs FDA nod for hemophilia A drug Esperoct but can’t launch until 2020 fiercepharma
February 24, 2019
Novo Nordisk just added a new therapy to its declining hemophilia stable, but it won’t be able to reap the benefit until 2020.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 13 14 Next page